KVUE
NYSE · USDKenvue Inc.
Consumer Defensive · Household & Personal Products
CEO Kirk L. Perry
Employees 22,000
R&D / revenue 2.5%
Last price
$18.91+1.29%last session
Market cap
$36.3B
P/E (TTM)
21.7x
From 52w high
−6.1%
From 52w low
+34.9%
1-year return
+35.7%
RSI 14 · vs SMA200
68.2 · +5.0%
IS score
61.9/ 100
Factor model across 8 sub-scores, ranked against 3,010 US stocks. Describes the business, not the outlook.
Download full factsheet (PDF)
One year, rebased to 100
KVUE SPY XLP (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universe56Profitability
53Growth
53Value
81Momentum
50Risk (safety)
79Quality
51Balance sheet
76Earnings quality
Flags
Strengths
✓ Piotroski 8+✓ FCF yield 5%+✓ Congress buying
Warnings
None of the computed warning flags fires for KVUE (Altman, Beneish, accruals, FCF, dilution).
Observations
Moat model: Wide, Intangible AssetsPiotroski 8 / 9Altman Z 2.3Beta 0.433 of 4 smart-money sources active
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.INSForm 4 · 180 days
Insider open-market buys
0
2 open-market sales, $746,679
Form 144 notices (12m): 2, $746,679 proposed, not confirmed sales
CONGSTOCK Act · 180 days
Congressional purchases
4
Last disclosed purchase 2026-06-16
Members disclose in ranges, 30-45 days after the trade
13F13F · quarter to 2026-06-30
Net change in institutional holders
−2
113 new holders, 102 closed
1,010 filers hold 95.0% · 411 added, 363 trimmed
ETFETF holdings · 30 days
Net funds accumulating
+287
1,139 funds adding shares
852 funds trimming · counts of funds, not dollars
DARKFINRA · daily
Short-sale share of off-exchange volume
33.8%
20-day avg 38.8%, 50-day avg 40.9%
Latest 5.0 pp under its 20-day average · a flow, not short interest
Key financials · FY2025
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Income statement
Revenue$15.1B
Revenue growth YoY−2.1%
Gross margin58.1%
Operating income$2.7B
Operating margin17.9%
Net income$1.5B
Net margin9.7%
EPS (diluted)$0.76
Cash flow
Operating cash flow$2.2B
Capital expenditure$475.0M
Free cash flow$1.7B
FCF conversion (FCF / OCF)78.4%
Stock-based compensation$136.0M
FCF less SBC$1.6B
Buybacks$0
Dividends$0
Balance sheet & returns
Cash & short-term investments$1.1B
Total debt$8.5B
Net debt$7.5B
Shareholders' equity$10.8B
Goodwill & intangibles$18.2B
Debt / equity0.80
ROE (TTM)15.6%
ROIC (TTM)10.1%
Operating margin by fiscal year
Revenue $15.1B (FY2021) to $15.1B (FY2025), a 0.1% CAGR.
Valuation
P/E (TTM)21.7x
EV / EBITDA13.8x
Price / sales2.36x
Price / FCF17.2x
FCF yield5.83%
Buyback yield0.00%
SBC / revenue0.4%
Price / book3.44x
Forward P/E FY202616.1x
Forward P/E FY202617.1x
Forward P/E FY202715.2x
Forward multiples divide today's price by Street EPS estimates. Street mean target $19.00 across 1 analysts last quarter is theirs, not ours.
KVUE vs industry median
112 companies in Household & Personal Products
KVUE (TTM)Industry median
Asset turnover 0.58 vs industry 0.81 · financial leverage 2.53
Earnings delivery
Next report 2026-11-02 · consensus EPS $0.2983%
beat rate, 10 of 12 quarters
+6.6%
median EPS surprise
5
longest beat streak
EPS surprise in % vs the consensus at the time, oldest (left) to newest, 2023-10-26 to 2026-08-06. Bars cap at ±60%.
Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| KVUE Kenvue Inc. | $36.3B | 21.7x | 15.6% | 10.8% | −2.1% | +35.7% |
| KMB Kimberly-Clark Corporation | $35.1B | 18.0x | 129.4% | 8.2% | −12.3% | −11.8% |
| EL The Estée Lauder Companies | $37.9B | 205.0x | 4.7% | -3.2% | +5.1% | +8.4% |
| CHD Church & Dwight Co., Inc. | $24.8B | 33.5x | 17.0% | 13.3% | +2.7% | +21.4% |
| CL Colgate-Palmolive Company | $75.0B | 37.0x | 434.3% | 12.9% | +5.2% | +21.3% |
| CLX The Clorox Company | $10.5B | 18.1x | 285.6% | 8.4% | −5.4% | — |
| ELF e.l.f. Beauty, Inc. | $6.7B | 113.4x | 6.0% | 13.9% | +31.2% | — |
| REYN Reynolds Consumer Products I | $4.8B | 13.9x | 15.5% | 9.4% | +2.7% | — |
12-month window: SPY +15.9%, sector ETF XLP +11.4%. Past returns describe history only.
Recent 8-K filings
2026-10-13Material Agreement; Exhibits
2026-08-06Earnings Release; Exhibits
2026-05-22Shareholder Vote
2026-05-07Earnings Release; Exhibits
2026-04-15Officer/Director Change; Exhibits
2026-02-17Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Financial Statements and Exhibits
Context
Shares outstanding1,920,773,400
Free float99.9%
Institutional ownership95.0%
Beta0.43
Dividend yield5.51%
Last dividend$0.21 on 2026-09-21
50 / 200-day average$18.34 / $18.06
Large-cap Consumer Defensive median P/E23.3x
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Wide).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where KVUE sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.ValuationProfitability (TTM)Returns on capitalGrowthMargin history & stabilityLiquidity (latest quarter)Leverage & solvency (latest quarter)EfficiencyCash flow & earnings qualityDividends & buybacksScores & forensic checksPer shareSize (TTM)
Valuation
| Measure | KVUE | Industry percentile |
|---|---|---|
| P/E (TTM) | 21.9x | 27th |
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.39 | 14th |
| Price / sales | 2.4x | 63rd |
| Price / book | 3.4x | 47th |
| Price / tangible book | — | |
| Price / free cash flow | 17.2x | 50th |
| Price / operating cash flow | 15.6x | 62nd |
| Enterprise value | $43.7B | 89th |
| EV / sales | 2.8x | 74th |
| EV / EBITDA | 13.8x | 38th |
| EV / EBIT | 16.8x | 29th |
| EV / free cash flow | 20.6x | 50th |
| Earnings yield | 4.6% | 84th |
| FCF yield | 5.8% | 58th |
| Operating cash flow yield | 6.4% | 47th |
| Graham number (per share) | $10.32 | 27th |
Profitability (TTM)
| Measure | KVUE | Industry percentile |
|---|---|---|
| Gross margin | 58.2% | 58th |
| EBITDA margin | 20.5% | 95th |
| Operating margin | 19.5% | 84th |
| EBIT margin | 16.9% | 89th |
| Net margin | 10.8% | 79th |
| NOPAT margin | 14.6% | 84th |
| FCF margin | 13.7% | 63rd |
| Operating cash flow margin | 15.1% | 63rd |
| R&D / revenue | 0.5% | 74th |
| SG&A / revenue | 29.2% | 47th |
| Stock comp / revenue | 0.4% | 11th |
| Effective tax rate | 25.4% | 74th |
Returns on capital
| Measure | KVUE | Industry percentile |
|---|---|---|
| ROE (on average equity) | 15.6% | 68th |
| ROA | 6.2% | 63rd |
| ROIC | 12.5% | 58th |
| ROCE | 12.5% | 68th |
| Return on tangible assets | 9.6% | 63rd |
| Cash ROIC (OCF / invested capital) | 13.0% | 47th |
| Gross profitability (GP / assets) | 33.5% | 37th |
| ROIC, 3-yr average | 7.7% | 47th |
| ROIC, 5-yr average | — | |
| ROE, 5-yr average | — | |
| Incremental ROIC | -268.9% | 16th |
Growth
| Measure | KVUE | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | 1.8% | 47th |
| Revenue growth (QoQ) | 1.2% | 37th |
| Revenue CAGR, 3 yr | 56.6% | 100th |
| Revenue CAGR, 5 yr | — | |
| Gross profit CAGR, 3 yr | 59.1% | 100th |
| Operating income CAGR, 3 yr | 62.4% | 100th |
| Net income growth (TTM YoY) | 16.9% | 90th |
| Net income CAGR, 3 yr | 56.8% | 90th |
| EPS growth (TTM YoY) | 17.2% | 80th |
| EPS CAGR, 3 yr | 56.6% | 90th |
| EPS CAGR, 5 yr | — | |
| FCF growth (TTM YoY) | 29.6% | 62nd |
| FCF CAGR, 3 yr | 47.1% | 92nd |
| Operating cash flow CAGR, 3 yr | 46.3% | 93rd |
| Book value CAGR, 3 yr | -1.6% | 41st |
| Dividend CAGR, 3 yr | -80.9% | 0th |
| Sustainable growth rate | 15.5% | 82nd |
Margin history & stability
| Measure | KVUE | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 57.9% | 68th |
| Operating margin, 3-yr average | 15.8% | 74th |
| Net margin, 3-yr average | 9.1% | 68th |
| FCF margin, 3-yr average | 12.0% | 79th |
| Revenue stability (0-1) | 0.59 | 32nd |
| Earnings stability (0-1) | 0.93 | 100th |
| Margin stability (0-1) | 0.98 | 89th |
Liquidity (latest quarter)
| Measure | KVUE | Industry percentile |
|---|---|---|
| Cash & short-term investments | $1.1B | 84th |
| Net cash (− = net debt) | −$7.4B | 5th |
| Working capital | $32.0M | 21st |
| Current ratio | 1.01 | 21st |
| Quick ratio | 0.71 | 42nd |
| Cash ratio (cash + ST investments / current liabilities) | 0.19 | 32nd |
| Defensive interval (days) | 247 days | 47th |
Leverage & solvency (latest quarter)
| Measure | KVUE | Industry percentile |
|---|---|---|
| Total debt | $8.5B | 89th |
| Debt / equity | 0.80 | 47th |
| Net debt / equity | 0.70 | 53rd |
| Debt / assets | 31.7% | 37th |
| Debt / capital | 44.6% | 47th |
| Debt / EBITDA | 2.68 | 44th |
| Net debt / EBITDA | 2.33 | 38th |
| Interest coverage (EBIT / interest) | 6.9x | 56th |
| Cash interest coverage | 6.2x | 50th |
| Debt payback (years of OCF) | 3.6 yrs | 56th |
| Liabilities / assets | 60.5% | 58th |
| IS credit model rating | BBB- | |
| Implied credit spread (bps) | 350 | 53rd |
Efficiency
| Measure | KVUE | Industry percentile |
|---|---|---|
| Asset turnover | 0.57 | 11th |
| Fixed asset turnover | 6.92 | 50th |
| Inventory turnover | 3.7 | 53rd |
| Receivables turnover | 6.4 | 21st |
| Days sales outstanding | 57 days | 79th |
| Days inventory outstanding | 99 days | 47th |
| Days payables outstanding | 146 days | 89th |
| Cash conversion cycle (days) | 10 days | 21st |
| Capex / revenue | 1.4% | 18th |
| Capex / depreciation | 0.37 | 12th |
| Operating expense ratio | 40.5% | 50th |
Cash flow & earnings quality
| Measure | KVUE | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.40 | 27th |
| FCF / net income | 1.28 | 36th |
| FCF / operating cash flow | 91.0% | 81st |
| Capex / operating cash flow | 9.0% | 19th |
| Accruals ratio | -2.5% | 89th |
| Sloan accruals ratio | -1.5% | 58th |
| Earnings quality score (0-1) | 1.00 | 73rd |
Scores & forensic checks
| Measure | KVUE | Industry percentile |
|---|---|---|
| IS score | 62 | 84th |
| IS profitability | 56 | 74th |
| IS growth | 53 | 74th |
| IS value | 53 | 84th |
| IS momentum | 81 | 89th |
| IS risk (safety) | 50 | 32nd |
| IS quality | 79 | 84th |
| IS balance sheet | 51 | 63rd |
| IS earnings quality | 76 | 79th |
| IS cash flow | 70 | 74th |
| Piotroski F-score (0-9) | 8 | 79th |
| Altman Z-score | 2.3 | 37th |
| Beneish M-score | −2.41 | 89th |
| Ohlson O-score | −7.82 | 26th |
| IS credit score | 54 | 47th |
Size (TTM)
| Measure | KVUE | Industry percentile |
|---|---|---|
| Market cap | $36.3B | 84th |
| Revenue | $15.4B | 84th |
| EBITDA | $3.2B | 89th |
| Net income | $1.7B | 84th |
| Free cash flow | $2.1B | 84th |
| Total assets | $26.7B | 95th |
| Shareholders' equity | $10.6B | 95th |
| Employees | 21,890 | 74th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Lawson Carlton Group President EMEA & LA |
Award / grant | 36,597 | $17.20 | $629,468 | 148,012 |
| 2026-10-02 | Orlando Matthew General Counsel |
Award / grant | 35,754 | $17.20 | $614,969 | 35,754 |
| 2026-10-02 | Orlando Matthew General Counsel |
Tax withholding | 14,749 | $17.20 | $253,683 | 21,005 |
| 2026-10-02 | Stevens Meredith Chief Operations Officer |
Award / grant | 35,754 | $17.20 | $614,969 | 129,375 |
| 2026-10-02 | Stevens Meredith Chief Operations Officer |
Tax withholding | 15,192 | $17.20 | $261,302 | 114,183 |
| 2026-10-02 | Tillett Caroline Chief Scientific Officer |
Award / grant | 24,732 | $17.20 | $425,390 | 86,180 |
| 2026-10-02 | Tillett Caroline Chief Scientific Officer |
Tax withholding | 8,471 | $17.20 | $145,701 | 77,709 |
| 2026-10-02 | Howlett Heather CFO & CAO |
Award / grant | 10,881 | $17.20 | $187,153 | 40,169 |
| 2026-10-02 | Howlett Heather CFO & CAO |
Tax withholding | 5,566 | $17.20 | $95,735 | 34,603 |
| 2026-10-01 | Wondrasch Michael Chief Tech & Data Officer |
Option exercise | 66,029 | — | — | 66,029 |
| 2026-10-01 | Wondrasch Michael Chief Tech & Data Officer |
Tax withholding | 21,031 | $17.22 | $362,154 | 44,998 |
| 2026-10-01 | Wondrasch Michael Chief Tech & Data Officer |
Option exercise | 66,029 | — | — | 132,056 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 20 | 268,270 | $2.5M |
| Open-market sale | Disposed | 2 | 42,191 | $746,679 |
| Option exercise | Acquired | 5 | 108,157 | — |
| Option exercise | Disposed | 5 | 108,157 | — |
| Tax withholding | Disposed | 7 | 73,182 | $1.3M |
Awards, option exercises and tax withholding are compensation mechanics; open-market buys and sales are the discretionary ones.
Form 144 notices
12 months: 2 notices · 42,192 shares · $746,679| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-06-10 | Howlett Heather | 3,700 | $66,988 |
| 2026-05-08 | Orlando Matthew | 38,492 | $679,691 |
| 2025-05-16 | Ruh Paul | 100,531 | $2.4M |
| 2025-05-12 | Ruh Paul | 50,000 | $1.2M |
A Form 144 is notice of a proposed sale, not a confirmed one.
Congress trades
12 months: House 26 trades (9 purchases) · Senate 1 (1 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-08-05 | Kevin Hern | House | Sale | $1,001 - $15,000 | 2026-08-11 |
| 2026-08-05 | Kevin Hern | House | Sale (Full) | $1,001 - $15,000 | 2026-08-11 |
| 2026-08-04 | Kevin Hern | House | Sale (Full) | $1,001 - $15,000 | 2026-08-11 |
| 2026-07-17 | Gilbert Cisneros | House | Sale | $1,001 - $15,000 | 2026-09-07 |
| 2026-03-27 | Alan Armstrong | Senate | Purchase | $1,001 - $15,000 | 2026-07-20 |
| 2025-08-28 | Sheldon Whitehouse | Senate | Sale (Full) | $1,001 - $15,000 | 2025-09-03 |
| 2025-08-28 | Sheldon Whitehouse | Senate | Sale | $1,001 - $15,000 | 2025-09-03 |
| 2025-08-28 | Sheldon Whitehouse | Senate | Sale (Full) | $1,001 - $15,000 | 2025-09-02 |
STOCK Act disclosures, in ranges, filed up to 45 days after the trade.
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| FMR LLC | 157,051,418 | $3.0B | 8.18% |
| BlackRock, Inc. | 150,825,694 | $2.9B | 7.85% |
| VANGUARD CAPITAL MANAGEMENT LLC | 125,314,564 | $2.4B | 6.52% |
| STATE STREET CORP | 121,619,054 | $2.3B | 6.33% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 93,303,762 | $1.8B | 4.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,021,320 | $990.2M | 2.71% |
| Independent Franchise Partners LLP | 50,427,994 | $963.7M | 2.63% |
| NORGES BANK | 46,156,826 | $882.1M | 2.40% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 44,715,586 | $861.9M | 2.33% |
| HBK INVESTMENTS L P | 28,000,001 | $535.1M | 1.46% |
| MORGAN STANLEY | 23,762,190 | $454.1M | 1.24% |
| GOLDMAN SACHS GROUP INC | 22,798,371 | $435.7M | 1.19% |
| SG Americas Securities, LLC | 22,723,981 | $434.3M | 1.18% |
| DIMENSIONAL FUND ADVISORS LP | 22,585,280 | $431.6M | 1.18% |
| BALYASNY ASSET MANAGEMENT L.P. | 19,860,108 | $379.5M | 1.03% |
Institutional ownership by quarter
% of shares held by 13F filers
Number of 13F filers holding
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1,010 | 95.0% | 113 | 411 | 363 | 102 |
| 2026-03-31 | 1,012 | 91.0% | 127 | 423 | 328 | 139 |
| 2025-12-31 | 1,043 | 94.5% | 198 | 371 | 393 | 187 |
| 2025-09-30 | 1,056 | 95.7% | 152 | 343 | 467 | 180 |
| 2025-06-30 | 1,100 | 99.6% | 147 | 455 | 401 | 107 |
| 2025-03-31 | 1,076 | 99.4% | 161 | 456 | 369 | 72 |
| 2024-12-31 | 1,004 | 100.4% | 137 | 403 | 373 | 105 |
| 2024-09-30 | 990 | 99.2% | 121 | 373 | 405 | 110 |
| 2024-06-30 | 986 | 97.7% | 140 | 431 | 326 | 94 |
| 2024-03-31 | 954 | 97.7% | 131 | 400 | 327 | 135 |
| 2023-12-31 | 974 | 97.3% | 198 | 404 | 303 | 111 |
| 2023-09-30 | 900 | 88.5% | 762 | 124 | 12 | 20 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-08-06 | SCHEDULE 13G/A | Abigail P. Johnson | 8.2% | 157,051,419 |
| 2026-05-06 | SCHEDULE 13G | Abigail P. Johnson | 7.0% | 135,093,093 |
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.5% | 143,924,768 |
| 2026-02-17 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 1.0% | 19,752,028 |
Required above 5% of a class; 13G is the passive form.
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.05% | $1.1B |
| VTSAX | 0.05% | $1.1B |
| VSMPX | 0.05% | $1.1B |
| VTI | 0.05% | $1.1B |
| VOO | 0.05% | $890.8M |
| VFINX | 0.05% | $890.8M |
Share structure
Shares outstanding1,920,773,400
Float1,917,988,345
Free float99.9%
Income statement
Fiscal years, USD| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $15.1B | $14.9B | $15.4B | $15.5B | $15.1B |
| Cost of revenue | $6.6B | $6.7B | $6.8B | $6.5B | $6.3B |
| Gross profit | $8.4B | $8.3B | $8.6B | $9.0B | $8.8B |
| R&D | $0 | $0 | $0 | $0 | $382.0M |
| SG&A | $5.5B | $5.6B | $6.1B | $6.0B | $6.1B |
| Operating income | $2.9B | $2.7B | $2.5B | $1.8B | $2.7B |
| EBITDA | $3.7B | $3.3B | $3.2B | $2.5B | $2.9B |
| Pretax income | $2.9B | $2.6B | $2.2B | $1.4B | $2.0B |
| Income tax | $847.0M | $573.0M | $526.0M | $385.0M | $529.0M |
| Net income | $2.1B | $2.1B | $1.7B | $1.0B | $1.5B |
| EPS, diluted | $1.10 | $1.08 | $0.87 | $0.54 | $0.76 |
| Diluted shares | 1.9B | 1.9B | 1.9B | 1.9B | 1.9B |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $740.0M | $1.2B | $1.4B | $1.1B | $1.1B |
| Receivables | $2.3B | $2.3B | $2.6B | $2.7B | $0 |
| Inventory | $1.7B | $2.2B | $1.9B | $1.6B | $1.7B |
| Total current assets | $4.9B | $5.9B | $6.1B | $5.5B | $5.7B |
| PP&E, net | $1.8B | $1.8B | $2.0B | $1.8B | $2.2B |
| Goodwill & intangibles | $20.5B | $19.0B | $18.9B | $17.3B | $18.2B |
| Total assets | $27.9B | $27.3B | $27.9B | $25.6B | $27.1B |
| Accounts payable | $1.8B | $1.8B | $2.5B | $2.3B | $2.5B |
| Total current liabilities | $4.0B | $3.9B | $5.5B | $5.7B | $5.9B |
| Long-term debt | $0 | $8.9B | $7.7B | $6.9B | $7.1B |
| Total liabilities | $7.5B | $7.3B | $16.6B | $15.9B | $16.3B |
| Shareholders' equity | $20.4B | $20.0B | $11.2B | $9.7B | $10.8B |
Cash flow statement
Outflows are negative| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | $2.0B | $2.1B | $1.7B | $1.0B | $1.5B |
| Depreciation & amortization | $731.0M | $644.0M | $627.0M | $622.0M | $557.0M |
| Stock-based compensation | $141.0M | $137.0M | $188.0M | $254.0M | $136.0M |
| Change in working capital | −$3.1B | −$513.0M | $797.0M | −$571.0M | $0 |
| Operating cash flow | $334.0M | $2.5B | $3.2B | $1.8B | $2.2B |
| Capital expenditure | −$295.0M | −$375.0M | −$469.0M | −$434.0M | −$475.0M |
| Free cash flow | $39.0M | $2.1B | $2.7B | $1.3B | $1.7B |
| Investing cash flow | −$171.0M | −$390.0M | −$488.0M | −$425.0M | −$436.0M |
| Net debt issued / repaid | −$7.0M | $14.0M | $8.2B | $159.0M | $0 |
| Buybacks | $0 | $0 | $0 | −$235.0M | $0 |
| Dividends paid | $0 | $0 | −$14.6B | −$1.6B | $0 |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Gross margin | 56.2% | 58.0% | 58.1% |
| Operating margin | 16.1% | 11.9% | 17.9% |
| Net margin | 10.3% | 6.7% | 9.7% |
| FCF margin | 16.8% | 8.6% | 11.4% |
| ROE | 10.7% | 9.9% | 14.4% |
| ROIC | 7.8% | 7.7% | 10.9% |
| ROA | 4.3% | 3.9% | 5.6% |
| Debt / equity | 0.75 | 0.90 | 0.79 |
| Interest coverage | 5.4x | 4.1x | 5.9x |
| Current ratio | 1.12 | 0.96 | 0.96 |
| Revenue growth | — | +33.3% | −2.1% |
| EPS growth | — | −14.4% | +43.4% |
| P/E at year end | 31.8x | 38.4x | 22.5x |
| EV / EBITDA at year end | 18.7x | 18.9x | 13.7x |
| FCF yield at year end | 5.13% | 3.38% | 5.22% |
| Dividend payout | 1,217.9% | 150.7% | 0.0% |
Revenue by segment
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Self Care | $6.5B | $6.5B | $6.4B |
| Essential Health | $4.6B | $4.7B | $4.6B |
| Skin Health and Beauty | $4.4B | $4.2B | $4.1B |
Revenue by region · FY2025
North America$7.3B · 48%
EMEA$3.7B · 25%
Asia Pacific$2.8B · 18%
Latin America$1.4B · 9%
Street estimates by fiscal year
Next report 2026-11-02 · consensus EPS $0.29 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $15.6B | $15.5B – $15.7B | $1.18 | $1.05 – $1.26 | 8 | 16.1x |
| 2026 | $15.4B | $15.3B – $15.5B | $1.11 | $1.10 – $1.12 | 8 | 17.1x |
| 2027 | $16.0B | $15.8B – $16.2B | $1.25 | $1.18 – $1.34 | 8 | 15.2x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-08-06 | $0.32 | $0.31 | −2.7% | $4.0B | $4.0B | −0.3% |
| 2026-05-07 | $0.26 | $0.32 | +22.1% | $3.8B | $3.9B | +1.7% |
| 2026-02-17 | $0.22 | $0.27 | +21.2% | $3.7B | $3.8B | +2.6% |
| 2025-11-03 | $0.26 | $0.28 | +7.6% | $3.8B | $3.8B | −1.5% |
| 2025-08-07 | $0.28 | $0.29 | +2.9% | $3.9B | $3.8B | −0.4% |
| 2025-05-08 | $0.23 | $0.24 | +5.5% | $3.7B | $3.7B | +1.7% |
| 2025-02-06 | $0.26 | $0.26 | 0.0% | $3.8B | $3.7B | −2.6% |
| 2024-11-07 | $0.27 | $0.28 | +2.8% | $3.9B | $3.9B | −0.5% |
| 2024-08-06 | $0.28 | $0.32 | +16.1% | $3.9B | $4.0B | +1.8% |
| 2024-05-07 | $0.25 | $0.28 | +10.2% | $3.8B | $3.9B | +2.7% |
| 2024-02-08 | $0.28 | $0.31 | +9.5% | $3.8B | $3.7B | −3.1% |
| 2023-10-26 | $0.30 | $0.31 | +3.3% | $3.9B | $3.9B | +0.2% |
| 2023-07-20 | $0.29 | $0.32 | +10.3% | $4.0B | $4.0B | +1.3% |
| 2023-06-02 | $0.32 | $0.19 | −40.6% | $3.9B | $3.9B | +0.0% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $315.9M | 16,709,438 | 75,279 |
| 2026-08-24 | $186.5M | 9,669,402 | 64,079 |
| 2026-08-17 | $169.8M | 8,939,587 | 61,135 |
| 2026-08-10 | $123.4M | 6,465,646 | 47,560 |
| 2026-08-03 | $239.9M | 12,493,802 | 73,495 |
| 2026-07-27 | $152.1M | 7,801,717 | 63,830 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 33.8% | 3,270,633 | 9,686,642 |
| 2026-10-14 | 30.2% | 3,035,444 | 10,040,919 |
| 2026-10-13 | 37.8% | 4,086,501 | 10,801,325 |
| 2026-10-12 | 24.2% | 1,371,262 | 5,660,288 |
| 2026-10-09 | 17.0% | 1,678,837 | 9,867,782 |
| 2026-10-08 | 37.5% | 1,202,640 | 3,205,297 |
| 2026-10-07 | 30.2% | 1,662,507 | 5,509,193 |
| 2026-10-06 | 23.8% | 1,043,431 | 4,384,127 |
| 2026-10-05 | 40.4% | 1,166,946 | 2,886,629 |
| 2026-10-02 | 45.8% | 2,626,073 | 5,735,957 |
A daily flow measure from FINRA, not short interest.
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| None on file. | |||
History, not a forecast.
Indicators
as of 2026-10-16RSI 1468.2
MFI78.5
ADX20.1
Stochastic %K / %D94.5 / 85.0
Williams %R-2.8
CCI306
TSI / signal3.2 / -14.5
Chaikin money flow0.12
ATR$0.33
Bollinger width8.9%
Volume vs 20-day avg0.60x
SupertrendUp
Moving averages and bands
level (price vs level)SMA 20$17.78 (+6.4%)
SMA 50$18.29 (+3.4%)
SMA 200$18.01 (+5.0%)
EMA 21$17.96 (+5.3%)
EMA 50$18.14 (+4.2%)
EMA 200$18.24 (+3.7%)
Bollinger upper$18.57 (+1.8%)
Bollinger lower$16.99 (+11.3%)
Parabolic SAR$17.30 (+9.3%)
Open the live chart, 110+ indicatorsAbout Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
https://www.kenvue.com
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Kirk L. Perry | Chief Executive Officer & Director | $2.9M | 1967 |
| Meredith Stevens | Chief Operations Officer | $1.8M | 1963 |
| Carlton Lawson | Group President of Europe, Middle East & Africa | $1.4M | 1969 |
| Matthew Orlando | General Counsel | $1.3M | 1977 |
| Michael Wondrasch | Chief Technology & Data Officer | $1.0M | 1969 |
| Caroline Tillett | Chief Scientific Officer | — | 1972 |
| Heather R. Howlett | Interim CFO & Chief Accounting Officer | — | 1978 |
| Jonathan Halvorson | Chief Digital & Marketing Officer | — | 1983 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Amit Banati Chief Financial Officer | 2025 | $553,846 | $6.4M | $644,193 | $15.2M |
| Thibaut Mongon Former Chief Executive Officer | 2025 | $747,145 | $6.0M | $0 | $10.9M |
| Kirk Perry Chief Executive Officer | 2025 | $566,346 | $2.7M | $0 | $7.5M |
| Michael Wondrasch Chief Technology & Data Officer | 2025 | $187,981 | $3.0M | $299,321 | $4.0M |
| Carlton Lawson Group President, Europe, Middle East & Africa | 2025 | $774,180 | $1.6M | $561,331 | $4.0M |
| Matthew Orlando General Counsel | 2025 | $647,500 | $1.4M | $445,609 | $3.3M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-09-21 | $0.21 | 2026-10-02 |
| 2026-08-12 | $0.21 | 2026-08-26 |
| 2026-05-13 | $0.2075 | 2026-05-27 |
| 2026-02-11 | $0.2075 | 2026-02-25 |
| 2025-11-12 | $0.2075 | 2025-11-26 |
| 2025-08-13 | $0.2075 | 2025-08-27 |
| 2025-05-14 | $0.205 | 2025-05-28 |
| 2025-02-12 | $0.205 | 2025-02-26 |
Moat model
Wide · Intangible Assets · 2026-06-28Cost advantage78
Intangibles90
Switching costs52
Network effect85
Efficient scale80
Our component scores (0-100) and overall 75.9; a model of the business, not a call on the stock.
InsiderStreet reports findings from filings and market data. Nothing on this page is a recommendation to buy or sell.Every figure is computed in code · data as of 2026-10-17